Antibacterial Treatment for Surgical-Wound Infection in Diabetes Patients

Bibliography link: A. L. Ryabov, I. N. Pasechnik. Antibacterial Treatment for Surgical-Wound Infection in Diabetes Patients // Doctor.Ru № 12 (129), 2016. Part І: 49–52.
A. L. Ryabov I. N. Pasechnik

Objective of the Review: To discuss the potential of antibacterial agents in treating surgical-wound infection (SWI) in diabetes patients.

Key Points: The introduction of antibiotic prophylaxis into wide clinical practice and the constant improvement of surgical techniques do not guarantee that SWI will be prevented. In diabetes patients undergoing surgery procedures, the rates and severity of SWI are increasing. A combination approach to treating SWI includes systemic antibacterial therapy. Our data show that parenteral ceftaroline, a cephalosporin antibiotic, combined with metronidazole is a safe alternative to a combination of carbapenems and vancomycin.

Conclusion: Treating SWI in diabetes patients requires a combination approach. Systemic antibacterial treatment should be administered, keeping in mind the polymicrobial nature of surgical infections.

A. L. Ryabov — Central Clinical Hospital with Outpatient Clinic at the Department of Presidential Affairs of the Russian Federation, Moscow. E-mail:

I. N. Pasechnik — Central State Medical Academy at the Department of Presidential Affairs of the Russian Federation, Moscow. E-mail:

  1. Богун Л. В. Инфекции у больных сахарным диабетом // Болезни и антибиотики. 2009. № 1. С. 24–29.
  2. Зузова А. П., Белькова Ю. А. Инфекции области хирургического вмешательства: общие подходы к антибиотикопрофилактике // Фарматека. 2007. № 4. С. 67–74.
  3. Пасечник И. Н., Рябов А. Л., Вершинина М. Г. Сепсис и сахарный диабет: состояние проблемы // Хирургия. Журн. им. Н. И. Пирогова. 2016. № 1. С. 80–84.
  4. Стратегия и тактика применения антимикробных средств в лечебных учреждениях России. Российские национальные рекомендации/ Под. ред. В. С. Савельева, Б. Р. Гельфанда, С. В. Яковлева М., 2012. 94 с.
  5. Хирургические инфекции кожи и мягких тканей. Российские национальные рекомендации / Под ред. В. С. Савельева. М., 2009. 89 с.
  6. Шляпников С. А. Хирургические инфекции мягких тканей. Подходы к диагностике и принципы терапии // Рус. мед. журн. 2006. Т. 14. № 28. С. 27–31.
  7. Bratzler D. W., Dellinger E. P., Olsen K. M., Perl T. M. et al.; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery // Am. J. Health Syst. Pharm. 2013. Vol. 70. N 3. P. 195–283.
  8. Chiasson J. L., Aris-Jilwan N., Bélanger R., Bertrand S. et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state // CMAJ. 2003. Vol. 168. N 7. P. 859–866.
  9. Chin-Hong P. V. Infections in patients with diabetes mellitus: importance of early recognition, treatment and prevention // Adv. Stud. Med. 2006. Vol. 6. N 2. P. 71–81.
  10. Edmiston C. E. Jr., Krepel C. J., Seabrook G. R., Jochimsen W. G. Anaerobic infections in the surgical patient: microbial etiology and therapy // Clin. Infect. Dis. 2002. Vol. 35. Suppl. 1. S112–118.
  11. Gorwitz R. J., Kruszon-Moran D., McAllister S. K., McQuillan G. et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004 // J. Infect. Dis. 2008. Vol. 197. N 9. P. 1226–1234.
  12. King J. T. Jr., Goulet J. L., Perkal M. F., Rosenthal R. A. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery // Ann. Surg. 2011. Vol. 253. N 1. P. 158–165.
  13. Koh G. C., Peacock S. J., van der Poll T., Wiersinga W. J. The impact of diabetes on the pathogenesis of sepsis // Eur. J. Clin. Microbiol. Infect. Dis. 2012. Vol. 31. N 4. P. 379–388.
  14. Mangram A. J., Horan T. C., Pearson M. L., Silver L. C. et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee // Infect. Control Hosp. Epidemiol. 1999. Vol. 20. N 4. P. 250–278.
  15. Muller L. M., Gorter K. J., Hak E., Goudzwaard W. L. et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus // Clin. Infect. Dis. 2005. Vol. 41. N 3. P. 281–288.
  16. Rayfield E. J., Ault M. J., Keusch G. T., Brothers M. J. et al. Infection and diabetes: the case for glucose control // Am. J. Med. 1982. Vol. 72. N 3. P. 439–450.
  17. Shah B. R., Hux J. E. Quantifying the risk of infectious diseases for people with diabetes // Diabetes Care. 2003. Vol. 26. N 2. P. 510–513
Новости мировой медицины! Свежие статьи из журнала! Будьте в курсе!

Похожие статьи

Similar article
19 April 00:00, Interview
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)
19 April 00:00, Paediatrics
A.V. Aksenov, E.A. Ivanovskaya
Successful Use of Tocilizumab in a Child with Systemic Juvenile Idiopathic Arthritis
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)